Helix Biopharma Corp. to Present at BIT Life Sciences' Third Annual International Congress of Antibodies in Beijing, China on March 25 – PR Inside

AURORA, ON — (Marketwire) — 03/23/11 — Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP), a developer of biopharmaceutical drug candidates for the prevention and treatment of cancer, today announced that Baomin Tian, Ph.D., senior …

Some local news is curated – Original might have been posted at a different date/ time! Click the source link for details.